What Has Changed in the Management of Uterine Serous Carcinomas? Two Decades of Experience

Uterine serous carcinoma accounts for 3–10% of endometrial cancers, but it is the most lethal histopathological subtype. The molecular characterization of endometrial carcinomas has allowed novel therapeutic approaches for these patients. We undertook a retrospective analysis of patients with uterin...

Descripción completa

Detalles Bibliográficos
Autores principales: Liontos, Michalis, Svarna, Anna, Theofanakis, Charalampos, Fiste, Oraianthi, Andrikopoulou, Angeliki, Kaparelou, Maria, Koutsoukos, Konstantinos, Thomakos, Nikolaos, Haidopoulos, Dimitrios, Rodolakis, Alexandros, Dimopoulos, Meletios Athanasios, Zagouri, Flora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628752/
https://www.ncbi.nlm.nih.gov/pubmed/34898589
http://dx.doi.org/10.3390/curroncol28060410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628752/
https://www.ncbi.nlm.nih.gov/pubmed/34898589
http://dx.doi.org/10.3390/curroncol28060410

Ejemplares similares